INFLUENCE OF CYP3A5 GENOTYPE ON THE PHARMACOKINETIC PROFILE OF TACROLIMUS IN PAEDIATRIC TRANSPLANT PATIENTS

被引：0
|
作者：
McLean, K.
Fung, A.
Gijsen, V.
Nalli, N.
Safi, M.
Daljevic, T.
Ogaki, C.
Mital, S.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2012年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2012.07.471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [21] Prediction of Tacrolimus Dosage and CYP3A5 Genotype By Pre-Transplant Single Dose Tacrolimus.
    Townamchai, N.
    Chancharoenthana, W.
    Vadcharavivad, S.
    Chariyavilaskul, P.
    Leelahavanichkul, A.
    Watanatorn, S.
    Avihingsanon, Y.
    Praditpornsilpa, K.
    TRANSPLANTATION, 2014, 98 : 886 - 886
  • [22] Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose
    Bergmann, Troels K.
    Hennig, Stefanie
    Barraclough, Katherine A.
    Isbel, Nicole M.
    Staatz, Christine E.
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 62 - 70
  • [23] Prediction of Tacrolimus Dosage and CYP3A5 Genotype By Pre-Transplant Single Dose Tacrolimus.
    Townamchai, N.
    Chancharoenthana, W.
    Vadcharavivad, S.
    Chariyavilaskul, P.
    Leelahavanichkul, A.
    Watanatorn, S.
    Avihingsanon, Y.
    Praditpornsilpa, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 886 - 886
  • [24] Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population
    Lalan, Shwetal
    Abdel-Rahman, Susan
    Gaedigk, Andrea
    Leeder, J. Steven
    Warady, Bradley A.
    Dai, Hongying
    Blowey, Douglas
    PEDIATRIC NEPHROLOGY, 2014, 29 (10) : 2039 - 2049
  • [25] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients
    Renders, L.
    Frisman, M.
    Ufer, M.
    Mosyagin, I.
    Haenisch, S.
    Ott, U.
    Caliebe, A.
    Dechant, M.
    Braun, F.
    Kunzendorf, U.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 228 - 234
  • [26] CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children
    Alvarez-Eliasa, A. C.
    Garcia-Rocaa, P.
    Velasquez-Jones, L.
    Valverde, S.
    Varela-Fascinetto, G.
    Medeiros, M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (02) : 631 - 634
  • [27] Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population
    Shwetal Lalan
    Susan Abdel-Rahman
    Andrea Gaedigk
    J. Steven Leeder
    Bradley A. Warady
    Hongying Dai
    Douglas Blowey
    Pediatric Nephrology, 2014, 29 : 2039 - 2049
  • [28] Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients
    Cusinato, Diego Alberto C.
    Lacchini, Riccardo
    Romao, Elen A.
    Moyses-Neto, Miguel
    Coelho, Eduardo B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 364 - 372
  • [29] Are our local recommendations for tacrolimus dose adjustment in kidney transplant patients based on CYP3A5 genotype adequate?
    Noble, Y.
    Buchler, M.
    Bouvarel, A.
    Longuet, H.
    Halimi, J. M.
    Gatault, P.
    Barin-Le Guellec, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 51 - 51
  • [30] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Can Hu
    Wen-jun Yin
    Dai-yang Li
    Jun-jie Ding
    Ling-yun Zhou
    Jiang-lin Wang
    Rong-rong Ma
    Kun Liu
    Ge Zhou
    Xiao-cong Zuo
    European Journal of Clinical Pharmacology, 2018, 74 : 1437 - 1447
12345